Literature DB >> 12928507

Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

Thomas E Nordahl1, Ruth Salo, Martin Leamon.   

Abstract

Methamphetamine use is on the rise, with an imminent upsurge of abuse and dependence reported across the United States. Currently, preliminary evidence suggests that methamphetamine dependence may cause long-term neural damage in humans, with concomitant deleterious effects on cognitive processes such as memory and attention. This selective review provides an outline and synthesis of studies that assess the neurotoxic mechanisms of methamphetamine, as well as those that evaluate the cognitive sequelae of methamphetamine abuse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928507     DOI: 10.1176/jnp.15.3.317

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  118 in total

Review 1.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

Review 2.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

3.  The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Authors:  Kimber L Price; Stacia M DeSantis; Annie N Simpson; Bryan K Tolliver; Aimee L McRae-Clark; Michael E Saladin; Nathaniel L Baker; Mark T Wagner; Kathleen T Brady
Journal:  Am J Addict       Date:  2011-07-18

4.  Neuropsychological deficits in adolescent methamphetamine abusers.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

5.  Extended access to methamphetamine self-administration affects sensorimotor gating in rats.

Authors:  Martin Hadamitzky; Athina Markou; Ronald Kuczenski
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

6.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Authors:  Grant N Colfax; Glenn-Milo Santos; Moupali Das; Deirdre McDermott Santos; Tim Matheson; James Gasper; Steve Shoptaw; Eric Vittinghoff
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 7.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

8.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

9.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

10.  Visual information processing in recently abstaining methamphetamine-dependent individuals: evoked potentials study.

Authors:  Jan Kremlácek; Ladislav Hosák; Miroslav Kuba; Jan Libiger; Jirí Cízek
Journal:  Doc Ophthalmol       Date:  2008-06-19       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.